Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 Jun 2025
// REUTERS
https://www.reuters.com/sustainability/boards-policy-regulation/23andme-seeks-new-bids-after-305-million-offer-its-co-founder-2025-06-04/
02 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/medtech/23andmes-anne-wojcicki-pushes-reopen-auction-backing-fortune-500-company
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088906/0/en/23andMe-Announces-Intent-to-Voluntarily-Delist-from-Nasdaq-and-Deregister-with-the-SEC.html
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3086574/37244/en/AI-Meets-Genomics-Predictive-Oncology-Breakthrough-Coincides-with-Regeneron-s-256M-23andMe-Acquisition.html
19 May 2025
// ENDPTS
19 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/19/3083892/0/en/Regeneron-A-Leading-U-S-Biotechnology-Company-to-Acquire-23andMe-in-Court-Supervised-Sale.html
ABOUT THIS PAGE